Published in J Cardiovasc Pharmacol on November 01, 1993
Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol Sci (1989) 4.41
Reductive cleavage of cystine disulfides with tributylphosphine. Methods Enzymol (1977) 1.68
A human cellular model for studying the regulation of glucagon-like peptide-1 secretion. Endocrinology (2001) 1.56
Stereoselectivity at the calcium channel: opposite action of the enantiomers of a 1,4-dihydropyridine. J Cardiovasc Pharmacol (1985) 1.49
Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem. Br J Pharmacol (1983) 1.48
Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br J Pharmacol (2001) 1.45
Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915. J Cardiovasc Pharmacol (1988) 1.40
Modification of vasopressin- and angiotensin II- induced changes by calcium antagonists in the peripheral circulation of anaesthetized rabbits. Br J Pharmacol (1985) 1.35
Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes. Circulation (1995) 1.32
Human lymphoblastoid interferon. Large scale production and partial purification. J Biol Chem (1977) 1.24
PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta. J Cardiovasc Pharmacol (1984) 1.19
Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. Gen Pharmacol (1993) 1.18
Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers. Biophys J (1995) 1.14
A rapid and sensitive assay for arginase. Anal Biochem (1980) 1.13
Vasodilator effects of quercetin in isolated rat vascular smooth muscle. Eur J Pharmacol (1993) 1.12
Effects of the new calcium antagonist PN 200-110 on the myocardium and the regional peripheral circulation in anesthetized cats and dogs. J Cardiovasc Pharmacol (1984) 1.11
Cardiovascular effects of apamin and BRL 34915 in rats and rabbits. Br J Pharmacol (1988) 1.06
Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress. Br J Pharmacol (1996) 1.05
Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels. Circulation (1996) 1.04
Vasopressin induced production of inositol trisphosphate and calcium efflux in a smooth muscle cell line. Biochem Biophys Res Commun (1985) 1.03
Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels. Cardiovasc Res (1997) 1.03
A comparison of josamycin with macrolides and related antibiotics on isolated rat atria. Eur J Pharmacol (1982) 1.02
Effect of PY 108-068, a new calcium antagonist, on general hemodynamics and regional blood flow in anesthetized cats: a comparison with nifedipine. J Cardiovasc Pharmacol (1982) 1.01
Electrophysiological effects of imipramine on bovine ventricular muscle and Purkinje fibres. Br J Pharmacol (1980) 1.00
Molecular determinants of stereoselective bupivacaine block of hKv1.5 channels. Circ Res (1997) 1.00
Effects of the two enantiomers, S-16257-2 and S-16260-2, of a new bradycardic agent on guinea-pig isolated cardiac preparations. Br J Pharmacol (1995) 0.99
Trapping and intramyocardial distribution of microspheres with different diameters in cat and rabbit hearts in vitro. Basic Res Cardiol (1982) 0.99
Electrophysiological effects of desipramine on guinea pig papillary muscles. Eur J Pharmacol (1979) 0.98
Lack of evidence for voltage dependent calcium channels on platelets. Biochem Biophys Res Commun (1985) 0.97
Solubilization of an active opiate receptor from Bufo marinus. Eur J Pharmacol (1980) 0.97
Functional expression of an inactivating potassium channel (Kv4.3) in a mammalian cell line. Cardiovasc Res (1999) 0.96
Ventricular tachycardia in a patient with congenital coronary arteriovenous fistula. Am Heart J (1992) 0.96
Assessing calcium antagonism on vascular smooth muscle: a comparison of three methods. J Pharmacol Methods (1983) 0.96
Ergotamine-induced constriction of cranial arteriovenous anastomoses in dogs pretreated with phentolamine and pizotifen. Cephalalgia (1983) 0.95
FTY720: dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects. Transplant Proc (2001) 0.95
Effects of the calcium antagonist PY 108-068 on myocardial tissues in vitro and on reflex tachycardia in vivo. J Cardiovasc Pharmacol (1983) 0.94
Effects of MiRP1 and DPP6 beta-subunits on the blockade induced by flecainide of Kv4.3/KChIP2 channels. Br J Pharmacol (2008) 0.94
Studies on the mechanism of action of the vasoconstrictive dihydropyridine, CGP 28392. Eur J Pharmacol (1984) 0.93
Growth of dissociated neurons in culture dishes coated with synthetic polymeric amines. Neurosci Lett (1984) 0.93
Electrophysiological effects of propafenone in untreated and propafenone-pretreated guinea-pig atrial and ventricular muscle fibres. Br J Pharmacol (1985) 0.93
Negative inotropic effect of somatostatin in guinea-pig atrial fibres. Br J Pharmacol (1985) 0.93
Effect of imipramine on calcium and potassium currents in isolated bovine ventricular myocytes. Eur J Pharmacol (1985) 0.93
Effects of chlorbutol on 45Ca movements and contractile responses of rat aorta and its relevance to the actions of Syntocinon. J Pharm Pharmacol (1984) 0.93
Mechanism of the vasodilator effects of the cardiotonic agent DPI 201-106. J Cardiovasc Pharmacol (1986) 0.92
Validation studies for the use of the microsphere method in cats and young minipigs. Basic Res Cardiol (1981) 0.92
Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels. Br J Pharmacol (1998) 0.91
Electrophysiological effects of propafenone on isolated guinea-pig ventricular muscle and sheep Purkinje fibres. Eur J Pharmacol (1985) 0.91
Role of K+ channel opening and stimulation of cyclic GMP in the vasorelaxant effects of nicorandil in isolated piglet pulmonary and mesenteric arteries: relative efficacy and interactions between both pathways. Br J Pharmacol (1998) 0.91
Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: possible lack of relationship to immunosuppressive activity. Br J Pharmacol (1996) 0.91
Effects of atorvastatin and simvastatin on atrial plateau currents. J Mol Cell Cardiol (2007) 0.90
Electrophysiological effects of imipramine in nontreated and in imipramine-pretreated rat atrial fibres. Br J Pharmacol (1983) 0.90
Structural determinants of potency and stereoselective block of hKv1.5 channels induced by local anesthetics. Mol Pharmacol (1998) 0.90
Electrophysiological effects of imipramine in guinea pig-myocardium [proceedings]. Br J Pharmacol (1978) 0.90
Effects of bupivacaine and a novel local anesthetic, IQB-9302, on human cardiac K+ channels. J Pharmacol Exp Ther (2001) 0.90
Effects of chronic quercetin treatment on hepatic oxidative status of spontaneously hypertensive rats. Mol Cell Biochem (2001) 0.90
Calcium influx inhibition by steroids and analogs in C2C12 skeletal muscle cells. Br J Pharmacol (1998) 0.90
Electrophysiological effects of E-3753, a new antiarrhythmic drug, in guinea-pig ventricular muscle. Br J Pharmacol (1989) 0.89
Comparison of cardiodepressant and vasodilator effects of PN 200-110 (isradipine), nifedipine and diltiazem in anesthetized rabbits. Am J Cardiol (1987) 0.89
Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells. FEBS Lett (1998) 0.89
Electrophysiological effects of platelet-activating factor (PAF-acether) in guinea-pig papillary muscles. Eur J Pharmacol (1985) 0.88
Mechanisms involved in SNP-induced relaxation and [Ca+]i reduction in piglet pulmonary and systemic arteries. Br J Pharmacol (2001) 0.88
Effects of several class I antiarrhythmic drugs on isolated rat aortic vascular smooth muscle. Gen Pharmacol (1997) 0.88
Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells. Biochem J (1987) 0.87
Increase of empty pool-activated Ca2+ influx using an intracellular Ca2+ chelating agent. Biochem Biophys Res Commun (1996) 0.87
Tonic and frequency-dependent Vmax block induced by imipramine in guinea pig ventricular muscle fibers. J Cardiovasc Pharmacol (1990) 0.87
PY 108-068, a new, potent, and selective inhibitor of calcium-induced contraction of rabbit aortic rings. J Cardiovasc Pharmacol (1982) 0.87
Imipramine blocks rapidly activating and delays slowly activating K+ current activation in guinea pig ventricular myocytes. Circ Res (1994) 0.87
Tonic and phasic Vmax block induced by 5-hydroxypropafenone in guinea pig ventricular muscles. J Cardiovasc Pharmacol (1988) 0.87
Modulation by prednisolone of calcium handling in skeletal muscle cells. Br J Pharmacol (1995) 0.87
Contribution of donor-specific antibodies to acute allograft rejection: evidence from B cell-deficient mice. Transplantation (1998) 0.86
Effect of somatostatin on 45Ca fluxes in guinea-pig isolated atria. Br J Pharmacol (1987) 0.86
Differential blockade of agonist- and depolarization-induced 45Ca2+ influx in smooth muscle cells. Am J Physiol (1989) 0.86
Effects of ropivacaine on a potassium channel (hKv1.5) cloned from human ventricle. Anesthesiology (1997) 0.86
Further characterization of the effects of imipramine on plateau membrane currents in guinea-pig ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.86
Stereoselectivity at the calcium channel: different profiles of hemodynamic activity of the enantiomers of the dihydropyridine derivative PN 200-110. J Cardiovasc Pharmacol (1986) 0.86
Effects of imipramine on the transient outward current in rabbit atrial single cells. Br J Pharmacol (1992) 0.86
Alkylation of cysteine thiols with 1,3-propane sultone. Methods Enzymol (1977) 0.85
Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle. Br J Pharmacol (1993) 0.85
Losartan and its metabolite E3174 modify cardiac delayed rectifier K(+) currents. Circulation (2000) 0.85
Serotonin increases the production of inositol phosphates and mobilises calcium via the 5-HT2 receptor in A7r5 smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.85
Acceleration of blood in the aorta: a parameter useful for evaluating cardiotonic and afterload reducing substances. J Pharmacol Methods (1981) 0.85
Electrophysiological effects of bunaphtine on isolated rat atria. Eur J Pharmacol (1980) 0.85
Very small microspheres are useful for the determination of cardiac output but not organ blood flow in conscious rabbits. Experientia (1981) 0.85
The mechanism of the positive inotropic action of ketamine on isolated atria of the rat. Br J Pharmacol (1982) 0.85
Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization. Mol Pharmacol (2001) 0.83
Electrophysiologic interactions between mexiletine and propafenone in guinea pig papillary muscles. J Cardiovasc Pharmacol (1989) 0.83
A simple cutter for fresh tissue to facilitate the investigation of intramyocardial blood flow with tracer microspheres in cats and rabbits. J Pharmacol Methods (1982) 0.83
Involvement of protein kinase C in reduced relaxant responses to the NO/cyclic GMP pathway in piglet pulmonary arteries contracted by the thromboxane A2-mimetic U46619. Br J Pharmacol (1997) 0.83
Cyclosporin A potentiates receptor-activated [Ca2+]c increase. J Recept Signal Transduct Res (1997) 0.83
PY 108-068: a calcium antagonist with an unusual pattern of cardiovascular activity. Gen Pharmacol (1985) 0.83
Benzocaine enhances and inhibits the K+ current through a human cardiac cloned channel (Kv1.5). Cardiovasc Res (1999) 0.83
Evidence of abnormal automaticity and triggering activity in incessant ectopic atrial tachycardia. Am Heart J (1988) 0.83
Reaction of cysteine thiol groups with 1,3-propane sultone: S-3-sulphopropyl as a modifying group for protein chemistry. Int J Pept Protein Res (1974) 0.82
Electrophysiological actions of chlorimipramine on guinea-pig ventricular fibres. Experientia (1979) 0.82
Electrophysiological effects of the combination of mexiletine and flecainide in guinea-pig ventricular fibres. Br J Pharmacol (1991) 0.82
The calcium antagonists PY 108-068 and verapamil diminish the effects of angiotensin II: sites of interaction in the peripheral circulation of anaesthetized cats. Br J Pharmacol (1984) 0.82
Effects of propafenone on 45Ca movements and contractile responses in vascular smooth muscle. Br J Pharmacol (1991) 0.82